[发明专利]胶质母细胞瘤危险分层模型及其在临床预后评估的应用有效
申请号: | 201811346520.2 | 申请日: | 2018-11-13 |
公开(公告)号: | CN109411012B | 公开(公告)日: | 2020-12-15 |
发明(设计)人: | 石金龙;陈奇;薛万国 | 申请(专利权)人: | 中国人民解放军总医院 |
主分类号: | G16B5/00 | 分类号: | G16B5/00;G16B30/10;G16B20/20 |
代理公司: | 北京领科知识产权代理事务所(特殊普通合伙) 11690 | 代理人: | 张丹 |
地址: | 100039*** | 国省代码: | 北京;11 |
权利要求书: | 查看更多 | 说明书: | 查看更多 |
摘要: | |||
搜索关键词: | 胶质 细胞 危险 分层 模型 及其 临床 预后 评估 应用 | ||
1.一种用于胶质母细胞瘤患者的预后风险评估系统,所述的预后风险评估系统包括数据输入模块、模型计算模块和结果输出模块,所述的模型计算模块通过风险分层模型计算获得胶质母细胞瘤患者的模型值,所述的风险分层模型为:
Y=Coe*X
Coe=(0.014927198,0.009302326,...,0.017309391),X=(v1,v2,...,v111)T,
所述的Coe=(0.014927198,0.009302326,0.006020697,0.009157401,0.008749802,0.012970721,0.014429021,0.006045153,0.009023346,0.009275152,0.009737098,0.008170105,0.001622246,0.009220806,0.010443604,0.004156609,0.012499717,0.007488961,0.006822309,0.002885804,0.008027898,0.013948959,0.014111999,0.006864881,0.01252689,0.011177283,0.016294921,0.008895632,0.004353162,0.012590295,0.017726048,0.012372908,0.005900229,0.007700913,0.008767012,0.012798623,0.005853128,0.004294287,0.006162904,0.002009918,0.006125767,0.00682865,0.015017776,0.004951881,0.011720749,0.013794977,0.01066099,0.004364032,0.01508118,0.016285863,0.016756867,0.001413917,0.004810579,0.010117525,0.007691855,0.010026947,0.014483368,0.009266095,0.004050633,0.001293449,0.001814271,0.003696474,0.00912117,0.01406671,0.003540681,0.006263445,0.002057924,0.017852857,0.001876769,0.014084826,0.005609474,0.0030262,0.012472544,0.004660221,0.009329499,0.003301556,0.003058808,0.009565001,0.016910849,0.007900183,0.014573945,0.004452798,0.012019655,0.00621091,0.006219062,0.001239102,0.00920269,0.017427142,0.009637463,0.003555173,0.003643939,0.014972487,0.015380087,0.01463735,0.010651933,0.010760626,0.017870972,0.006777926,0.004264396,0.013939902,0.01175698,0.016077534,0.01293449,0.005075972,0.007195489,0.002834175,0.003175653,0.003180182,0.011711691,0.011032359,0.017309391);所述的X中v1,v1,……v111为与所述的风险系数相对应的甲基化位点(cg07464524,cg09912841,cg11426662,cg25560327,cg24550026,cg09692771,cg13681847,cg16483490,cg20623601,cg24046888,cg25124739,cg02970696,cg05726118,cg07556134,cg12508343,cg18011163,cg24105729,cg00202441,cg01483139,cg02647878,cg02968741,cg08660876,cg09760963,cg18016365,cg07862423,cg13593479,cg17621438,cg04488476,cg09013068,cg12798992,cg00376553,cg01900030,cg02204205,cg02316066,cg05231706,cg05898452,cg06586813,cg08300570,cg11139102,cg11274371,cg15774495,cg18071865,cg21517389,cg21808635,cg22281380,cg23104539,cg25819027,cg27006764,cg01981354,cg24820936,cg24828864,cg17028652,cg12041266,cg16036142,cg21558509,cg12836863,cg26740195,cg04352704,cg00645339,cg04025675,cg05896902,cg09093388,cg10088041,cg19114050,cg24328539,cg25908973,cg26796135,cg00291054,cg01769813,cg06330323,cg06788514,cg06846976,cg07549381,cg07644807,cg08779982,cg08936056,cg26819590,cg06270615,cg06788790,cg07780782,cg09967973,cg10792831,cg17833746,cg18711081,cg19636308,cg25330422,cg26111030,cg05724997,cg14623989,cg14889643,cg17602451,cg21793948,cg23707289,cg26277730,cg06346838,cg08165462,cg12400781,cg13368085,cg13422347,cg14559388,cg24156854,cg00876694,cg01118078,cg02872693,cg16626405,cg16810054,cg17204562,cg21859623,cg26204638,cg19810954,cg26237628)的甲基化率,阈值为0.4385954。
该专利技术资料仅供研究查看技术是否侵权等信息,商用须获得专利权人授权。该专利全部权利属于中国人民解放军总医院,未经中国人民解放军总医院许可,擅自商用是侵权行为。如果您想购买此专利、获得商业授权和技术合作,请联系【客服】
本文链接:http://www.vipzhuanli.com/pat/books/201811346520.2/1.html,转载请声明来源钻瓜专利网。